Penn National Gaming Moves All In on Reopening Efforts
An update on its gaming and racing properties helped boost Penn National Gaming shares to close out the week.
All Work
Chris Lange
DraftKings Ups the Ante in Secondary Offering
DraftKings is moving forward with its secondary offering, but it will be upsized from the previous announcement.
2020 IPO Next-Gen Cancer Screening AnPac Sees Growth in US and China
The announcement that AnPac Bio-Medical Science has entered into a three-year strategic cancer screening collaboration contract with Beijing Yuan Jian Health Management in China lit a fire under the shares Friday morning.
Are Smith & Wesson Earnings Really Not Enough for Investors?
Strong consumer demand for firearms helped Smith & Wesson deliver growth and market share gains in its firearms business in fiscal 2020.
Why Spotify’s DC Deal Is All Around Super
Spotify Technology is putting on its cape and saving the day for investors with its newest superhero deal with DC Comics.
How Sarepta and Selecta Bio Are Taking the Fight to DMD
Selecta Biosciences and Sarepta Therapeutics have announced that they had entered into a research license and option agreement.
Has Alpine Immune Sciences Found the Deal of a Lifetime?
Alpine Immune Sciences shares doubled on Thursday after the company announced a license agreement with AbbVie for its ALPN-101.
Kroger Earnings: When Good Isn’t Good Enough
Kroger reported better than expected fiscal first-quarter financial results before the markets opened on Thursday, but shares retreated on a lack of guidance.
Why This Analyst Sees Beyond Meat’s Prospects Improving
Beyond Meat has announced a new product line just in time for summer, and one key analyst has hiked his target price for the faux meat firm as well.
One Analyst Has Risked a Big Buy Rating on Nikola Stock
Nikola shares saw a handy gain on Wednesday after the first analyst got behind this electric vehicle manufacturer.
Aclaris Therapeutics Takes the Next Big Step Toward COVID Treatment
Aclaris Therapeutics has received an update from FDA regarding the use of its ATI-450 in hospitalized patients with COVID-19.
DraftKings Decides to Capitalize With Secondary Offering
Companies usually pursue secondary offerings as a way to raise capital after their stock has made a solid run. This is the case with DraftKings.
Is Groupon Back on Track After Q1?
Groupon reported first-quarter financial results after markets closed on Tuesday. The company said that it had a net loss of $1.63 per share and $374.2 million in revenue, beating analysts' consensus estimates on both…
Are Oracle Earnings Good Enough For Investors?
Oracle released fiscal fourth-quarter results after markets closed Tuesday. The firm reported $1.20 in earnings per share and $10.44 billion in revenue. Consensus estimates called for $1.16 in EPS and revenue of $10.67 billion.
How Weight Watchers’ Parent Just Became the Newest COVID-19 Stock
Weight Watchers is looking to deal with the excess weight that some people may have put on during the pandemic stay-at-home period.
Royalty Pharma Enters the Market With a Bang
Royalty Pharma shares entered the market with a bang on Tuesday.
Why This Analyst Just Got Very Bullish on the iPhone 12
Apple has largely weathered the coronavirus pandemic on the back of its Services business, but Wedbush Securities sees it rising even higher on its bread and butter business — iPhone sales.
How Digital Ally Is Holding Police Officers More Accountable
Digital Ally stock looks to be done running for now, though it easily could pick up again, as demand for body cameras remains incredibly high.
Meet Sanofi’s Big New Investment Into a COVID-19 Vaccine
Sanofi's announcement that it would be investing in a COVID-19 vaccine production site in France gave shares a boost early Tuesday.
Daunting Flight, Simulator Tests Lie Ahead for Boeing Stock
Even when the 737 Max is cleared to fly again, Boeing will have to deal with reduced demand and increased oversight.